Study on the Anti-apoptosis Effect of Insulin-like Growth FactorⅠon the Regulation of Neural Precursor Cells Survival

TANG Mei, WANG-qi, LI He-dong. et al

Abstract

To investigate the effect of insulin-like growth factor Ⅰ (IGF-Ⅰ) on the anti-apoptosis of neural precursor cells. Methods?Rat neural precursor cells (Ge6) were used as experiment object. 10 ng/mL IGF-Ⅰ were applied to cultured Ge6 differentiated 2 d, 4 d, 6 d and the untreated cells as control. Quantitative reverse transcriptase PCR (qRT-PCR) was used to detect the effect of the IGF-Ⅰ on caspase-3 mRNA in the Ge6 of different groups and Immunofluorescent staining were applied to obverse the positive rate of caspase-3. Results?qRT-PCR demonstrated that caspase-3 mRNA level of experimental group decreased compared to that of the control group, the differences between experimental group cultured for 4 d (2.007±0.297), 6 d (1.194±0.244) and the control group cultured for 4 d (5.530±1.027), 6 d (5.371±0.513) were statistically significant (P<0.05). Immunofluorescent staining indicated that the caspase-3 positive rate of experimental group cultured for 2 d, 4 d and 6 d were reduced compared to that of the control group, the differences between experimental group cultured for 4 d (3.5%±0.2%), 6 d (5.1%±0.1%) and the control group cultured for 4 d (7.0%±0.5%), 6 d (7.4%±0.4%) were statistically significant (P<0.05). Conclusion?IGF-I plays an anti-apoptosis role on neural precursor cells.

 

Keywords: Neural precursor cells Insulin-like growth factor Ⅰ, Apoptosis, Caspase-3 

 

Full Text:

PDF


References


Shoba L. An MR, Frank S, etal. Developmental regulation insulin-like growth factor- I and growth hormone receptor gene expression. Mol Cell Endocrinol, 1999;25;152(l-2): 125-136.

Russo VC, Gluckman PD, Feldman EL,et at. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev, 2005; 26 (7); 916-943.

Walenkamp MJ, Van der Kamp HJ, Pereira AM. et al. A variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor. Clin Endocrinol Metab. 2006; 91 ( 8); 3062- 3070.

Raile K, Klammt J, Schneider A, et al. Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor I receptor( IGF I R) mutation; implications for a gene dosage effect of the human IGF I R. Clin Endocrinol Metab, 2006; 91 (6);2264-2271.

Inagaki K, Tulpakov A, Rubtsov P, et al. A family insulin-like growth factor- I receptor mutant leads to short stature: clinical and biochemical characterization. Clin Endocrinol Metab. 2007; 92(4);1542-1548.

Villa P. Kaufmann SH. Eamshaw WC. Caspases and caspase inhibitors. Trends Biochem Sci, 1997;22(10):388-393.

Joseph D'Ercole A, Ye P. Expanding the mind; insulin-like growth factor I and brain development. Endocrinology, 2008; 149(12):5958-5962.

Arsenijeric Y, Weiss S. Insulin-like growth factor- is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors; distinctactions from those of brain-derived neurotrophic factor.J Neurosci, 1998; 18(6) :2118-2128.

Wang JM. Hayashi T. Zhang WR. Et al. Reduction of inchemic damage by application of insulin-like growth factor- I in rat brain aftert ransient ischemia. Acta Med Okayama.2001;55(1): 25-30.


Refbacks

  • There are currently no refbacks.